PRNP and neuroblastoma: As an alternative approach for testing whether PrPC sialylation status could be altered by changing the levels of cellular NEUs, neuroblastoma N2a cells were treated with DANA (2,3-didehydro-2-deoxy-N-acetylneuraminic acid) (Fig 5).